https://www.selleckchem.com/pr....oducts/resatorvid.ht
05). However, there was no difference in HbA1C levels regarding the treatment response to IVBI and IVDI. Renal function was significantly worse in patients with a poor response to IVBI and IVDI. Renal function could be used as a possible predictor for treatment response in certain DME patients. Further, for DME patients with poor responses to anti-VEGF or steroid treatments, assessment of renal function could help explain the poor treatment response. Renal function was significantly worse in patients with a poor response to IVBI and
Like
Comment
Share
